Overview of nosocomial infections caused by gram-negative bacilli.

By R. Gaynes, J. Edwards. Clinical Infectious Diseases, 2005

1,416 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Guidelines for the prevention of intravascular catheter-related infections. (2002, neutral): “For example, CLABSI is a term used by CDC's National Healthcare Safety Network (NHSN) (NHSN CLABSI information: http://www.cdc.gov/nhsn/psc_da.html) [206].”
Global Challenge of Multidrug-Resistant Acinetobacter baumannii (2007, background): “The statistics compiled as a result of surveillance efforts illustrate the emergence of many genera of bacteria that are resistant to all antibiotics (57, 60).”
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms (2009, background): “aeruginosa as the second most common cause of nosocomial pneumonia, health care-associated pneumonia, and ventilator-associated pneumonia (64, 106) and the leading cause of pneumonia among pediatric patients in the intensive care unit (ICU) (214).”
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. (2006, neutral): “ble for hospital-acquired infections [2].”
Guidelines for the prevention of intravascular catheter-related infections. (2011, neutral): “coli has increased significantly as has imipenem and ceftazidine resistance among Pseudomonas aeruginosa.(209) Candida spp.”
Acinetobacter baumannii: Emergence of a Successful Pathogen (2008, background): “6% of ICU-acquired UTIs in one study (187).”